Routine

Thin basement membrane nephropathy (benign familial haematuria)

TBMN · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Usually benign cause of persistent/recurrent glomerular haematuria due to diffusely thinned GBM, often from heterozygous COL4A3/COL4A4 variants. Most retain normal function, but a minority progress, so proteinuria and BP must be monitored.

Red flags

  • New or increasing proteinuria
  • Declining eGFR
  • Hearing loss or ocular changes (suggests Alport)
  • Family history of kidney failure
  • Visible haematuria with clots (consider urological cause)

Assessment

Differential diagnosis

  • Alport syndrome (carrier/autosomal)
  • IgA nephropathy
  • Other glomerulonephritis
  • Urological bleeding source
  • Hypercalciuria/hyperuricosuria
  • Exercise-induced haematuria

Investigations

  • Urinalysis/microscopy (dysmorphic RBCs, no/low proteinuria)
  • Urine ACR/PCR
  • Renal function
  • Family history and urinalysis of relatives
  • Audiometry/ophthalmology to exclude Alport features
  • Genetic testing or biopsy with EM (thin GBM) only if diagnosis uncertain or proteinuria present

Management

  • Confirm persistent glomerular haematuria with dysmorphic red cells and minimal proteinuria
  • Exclude urological causes in older patients or where risk factors exist (imaging, cystoscopy as indicated)
  • Take a family history and consider screening relatives for haematuria
  • Distinguish from Alport by assessing hearing, eyes, proteinuria and family history of kidney failure
  • Reserve biopsy/genetics for atypical features: significant proteinuria, declining eGFR, or suspected Alport
  • Reassure if isolated haematuria with normal function and no proteinuria (benign course)
  • Treat hypertension and any proteinuria with an ACE inhibitor/ARB
  • Avoid unnecessary nephrotoxins
  • Arrange periodic monitoring of BP, eGFR and ACR
  • Escalate to full Alport work-up if proteinuria develops or function declines
  • Provide genetic counselling where a pathogenic COL4 variant is identified
  • Document long-term follow-up plan

Drugs & doses

Ramipril 2.5-10 mg PO daily (only if proteinuria/hypertension)
Losartan 50-100 mg PO daily (alternative)

Disposition

Primary care or nephrology clinic monitoring. Reassurance for classic benign cases. Nephrology/genetics referral if proteinuria, declining function or Alport features.

Complications & pitfalls

  • Minority progress to CKD (overlap with autosomal Alport)
  • Unnecessary invasive investigation if misattributed
  • Missed urological malignancy if haematuria not fully assessed in older patients

Exam pearls

  • Isolated haematuria with normal function and no proteinuria is usually benign
  • Proteinuria or declining function should prompt Alport work-up
  • Family urinalysis is a cheap, informative test
  • Genetically it overlaps with autosomal-dominant Alport (COL4A3/4)
  • Still exclude urological causes of haematuria in older patients

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.